Something ‘LRRK -ing’ in the data

Over recent years, researchers have been identifying genetic variations associated with an increased risk of developing Parkinson’s. A recent study has thrown further light on the connection between certain genetic risk factors and Parkinson’s progression.

Important phase 1 trial results for LRRK2 inhibitor drug

This week the biotech company Denali Therapeutics announced the results of a phase 1 clinical trial of their LRRK2 inhibitor drug called ‘DNL151’. Their findings have interesting implications for the Parkinson’s community.

News CP news

The Duchess of Gloucester and Mike Tindall mark Parkinson’s Awareness Month

April marks World Parkinson’s Awareness Month to highlight the condition that affects some seven to 10 million people globally. At the centre of this month is World Parkinson’s Day on 11 April.

News Fundraising news

Jane Birkin’s 5-50-500 TRYathlon Challenge

On 5 May, Cure Parkinson’s supporter Jane Birkin will begin her 5-50-500 TRYathlon, a fundraising challenge she created to mark her 50th birthday!

News Research news

PD Avengers webinar hosted by Cure Parkinson’s: Women with Parkinson’s

Can meeting the needs of women living with Parkinson’s unlock new treatments to better manage, slow, stop or even cure Parkinson’s? Re-watch our recent webinar.